miR-184 represses β-catenin and behaves as a skin tumor suppressor.

Autor: Turovsky L; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel.; Skin Cancer Research lab, Clinical research institute (CRIR), Rambam Health Care Campus, Haifa, 31096, Israel., Kheshaiboun G; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel.; Skin Cancer Research lab, Clinical research institute (CRIR), Rambam Health Care Campus, Haifa, 31096, Israel., Yassen G; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel., Nagosa S; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel., Boyango I; Skin Cancer Research lab, Clinical research institute (CRIR), Rambam Health Care Campus, Haifa, 31096, Israel., Amitai-Lange A; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel., Bhattacharya S; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel., Ilan N; Cell Biology and Cancer Science, The Ruth and Bruce Rappaport Faculty of Medicine, Technion Integrated Cancer Center, Technion Israel Institute of Technology, Haifa, 31096, Israel., Vlodavsky I; Cell Biology and Cancer Science, The Ruth and Bruce Rappaport Faculty of Medicine, Technion Integrated Cancer Center, Technion Israel Institute of Technology, Haifa, 31096, Israel., Aberdam D; Université de Paris Cité, INSERM U1138, Centre des Cordeliers, Paris, France., Shalom-Feuerstein R; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel., Avitan-Hersh E; Skin Cancer Research lab, Clinical research institute (CRIR), Rambam Health Care Campus, Haifa, 31096, Israel. emily@technion.ac.il.; Cell Biology and Cancer Science, The Ruth and Bruce Rappaport Faculty of Medicine, Technion Integrated Cancer Center, Technion Israel Institute of Technology, Haifa, 31096, Israel. emily@technion.ac.il.

Publikováno v: Cell death & disease [Cell Death Dis] 2024 Feb 26; Vol. 15 (2), pp. 174. Date of Electronic Publication: 2024 Feb 26.